- Home
- EVGOW vs HUMAW Comparison
EVGOW vs HUMAW Comparison
Compare EVGOW & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGOW
- HUMAW
- Stock Information
- Founded
- EVGOW 2010
- HUMAW 2004
- Country
- EVGOW United States
- HUMAW United States
- Employees
- EVGOW 331
- HUMAW 220
- Industry
- EVGOW Other Specialty Stores
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- EVGOW Consumer Discretionary
- HUMAW Health Care
- Exchange
- EVGOW Nasdaq
- HUMAW Nasdaq
- Market Cap
- EVGOW N/A
- HUMAW N/A
- IPO Year
- EVGOW N/A
- HUMAW N/A
- Fundamental
- Price
- EVGOW $0.20
- HUMAW $0.55
- Analyst Decision
- EVGOW
- HUMAW
- Analyst Count
- EVGOW 0
- HUMAW 0
- Target Price
- EVGOW N/A
- HUMAW N/A
- AVG Volume (30 Days)
- EVGOW 74.7K
- HUMAW 14.2K
- Earning Date
- EVGOW 03-07-2025
- HUMAW 03-21-2025
- Dividend Yield
- EVGOW N/A
- HUMAW N/A
- EPS Growth
- EVGOW N/A
- HUMAW N/A
- EPS
- EVGOW N/A
- HUMAW N/A
- Revenue
- EVGOW $239,306,000.00
- HUMAW N/A
- Revenue This Year
- EVGOW N/A
- HUMAW N/A
- Revenue Next Year
- EVGOW N/A
- HUMAW N/A
- P/E Ratio
- EVGOW N/A
- HUMAW N/A
- Revenue Growth
- EVGOW 73.08
- HUMAW N/A
- 52 Week Low
- EVGOW $0.12
- HUMAW $1.18
- 52 Week High
- EVGOW $1.99
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- EVGOW 39.81
- HUMAW N/A
- Support Level
- EVGOW $0.19
- HUMAW N/A
- Resistance Level
- EVGOW $0.22
- HUMAW N/A
- Average True Range (ATR)
- EVGOW 0.02
- HUMAW 0.00
- MACD
- EVGOW -0.00
- HUMAW 0.00
- Stochastic Oscillator
- EVGOW 32.58
- HUMAW 0.00
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.